Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Search Results

Your search returned 1870 record(s).

Page 122 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:

  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1211 9.9 months Melanoma 5 University of Colorado Health Sciences Center United States 2/2011
Treatment Details: Patients: This phase 2 study involved 34 melanoma patients who had not received prior chemotherapy. The median patient age was 63 years and 67.6 were male. Treatment: Patients were tre
1212 9.9 months Castration-resistant prostate cancer 4 Chemotherapy
Air Force Hospital Greece 7/2012
Treatment Details: Patients: This study involved 38 men with previously treated castration-resistant prostate cancer with a median age of 74.5 years. Treatment: Patients were treated with the chemotherapy
1213 9.9 months Advanced hepatocellular carcinoma 3 Biologic therapy
National Cancer Centre Singapore 6/2012
Treatment Details: Patients: This study involved 42 advanced hepatocellular carcinoma patients with a median age of 62 years. Patient gender distribution was not provided. Treatment: Patients were treate
1214 9.9 months Advanced or recurrent NSCLC 5 Chemotherapy
University of Torino Italy 11/2002
Treatment Details: Patients: This Phase III study involved a total of 607 patients with advanced (stage IIIB or IV or recurrent) non-small cell lung cancer. Patients were divided into three groups. Group A c
1215 9.9 months Recurrent GBM 4 Gene Therapy
The University of Texas M.D. Anderson Cancer Center United States 7/2003
Treatment Details: Patients: This Phase I study involved 15 patients with recurrent gliomas. Of the fifteen, 13 patients had recurrent glioblastoma multiforme. All patients had prior radiotherapy and most ha
1216 9.9 months Advanced NSCLC 5 Chemotherapy
The Sarah Cannon Cancer Center and Tennessee Oncology United States 9/2002
Treatment Details: Patients: This Phase II study involved a total of 267 patients with advanced (Stage IIIB and IV) non-small-cell lung carcinoma. Patients were divided into 4 groups: Group A contained 71 pat
1217 9.9 months Stage IIIB/IV NSCLC 5 Chemotherapy
Penn State Cancer Institute United States 1/2008
Treatment Details: Patients: This phase III study involved 444 patients with stage IIIB/IV non-small-cell lung cancer. The median age was 65, ranging from 28 to 92 years old. There were more men than women
1218 9.9 months NSCLC 5 Chemotherapy
National Cancer Center Singapore 7/2010
Treatment Details: Patients: This was a “2-arm” study in which patients with advanced non-small-cell lung cancer were separated into two treatment groups, called arm A and arm B. Arm A consisted of 190 patie
1219 9.9 months Metastatic or recurrent breast cancer 5 Biologic therapy
The Ottawa Hospital Cancer Centre Canada 9/2010
Treatment Details: Patients: This study involved women with metastatic or recurrent breast cancer who had previously received chemotherapy. Patients were divided into 2 treatment groups. Group 1 consisted o
1220 9.9 months Extensive-stage SCLC 5 Chemotherapy
University of California Davis Cancer Center United States 5/2010
Treatment Details: Patients: This phase III trial involved patients with extensive-stage small cell lung cancer (E-SCLC) that had not received previous therapy. Patients were divided into 2 separate treatmen
Page 122 of 187  | Previous Page  | Next Page